Ciara Ruth Gavin

Arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) are used in differentiation therapy for certain kinds of leukemia. For my summer project, I am working under Dr Tracey O’Donovan to learn more about how these compounds affect leukemia cells, with the hopes of using them to treat other kinds of leukemia in the future. Differentiation therapy is really effective, providing a long-term cure for 90% of patients, so being able to apply it to other kinds of leukemia could make a huge difference to people with the disease.

Back
Start year
2021
End year
2021
Principal Investigator
Dr Sharon McKenna & Dr Tracey O'Donovan
Researcher
Ciara Ruth Gavin
Institute
UCC
Grant funding
Inaugural Summer Scholarship
Cancer
Leukemia
Linked To Breakthrough Cancer Research Priorities
1, 4, 6

View More